PMID: 12755837May 21, 2003Paper

Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use

Alimentary Pharmacology & Therapeutics
R M KlokJ R B J Brouwers

Abstract

Proton pump inhibitors have a prominent role in the management of acid-related diseases. Controlling expenses on proton pump inhibitors would yield great economic benefits for Dutch health care. To investigate whether clinical differences in proton pump inhibitors exist. We searched Medline, EMBASE and the Cochrane Library. We identified papers in English, German, French or Dutch in which two or more proton pump inhibitors were compared under the same clinical conditions in gastro-oesophageal reflux disease, peptic ulcer disease or Helicobacter pylori eradication. The pooled relative risks were calculated using the Mantel-Haenszel method. Two significant differences were found in the proton pump inhibitors compared. In gastro-oesophageal reflux disease, esomeprazole 40 mg was superior to omeprazole 20 mg (relative risk, 1.18; 95% confidence interval, 1.14-1.23). In peptic ulcer disease, pantoprazole 40 mg was superior to omeprazole 20 mg (relative risk, 1.07; 95% confidence interval, 1.02-1.13). In Helicobacter pylori eradication, no significant differences were found. Both significant differences found were in favour of the highest dose of proton pump inhibitor on a milligram basis. This indicates that the difference may be do...Continue Reading

References

Feb 1, 1995·Alimentary Pharmacology & Therapeutics·L WitzelW Schepp
Mar 1, 1995·Scandinavian Journal of Gastroenterology·P EkströmH Sellström
Dec 1, 1995·Alimentary Pharmacology & Therapeutics·R CorinaldesiC Maier
Oct 1, 1996·Alimentary Pharmacology & Therapeutics·A S Mee, J L Rowley
Sep 1, 1995·Journal of Gastroenterology and Hepatology·F Y ChangS D Lee
Jul 15, 1998·Alimentary Pharmacology & Therapeutics·G C SpinziG Minoli
Dec 21, 2000·Alimentary Pharmacology & Therapeutics·S Veldhuyzen Van ZantenP Sinclair
Jun 26, 2001·Alimentary Pharmacology & Therapeutics·J P GisbertJ M Pajares
Oct 31, 2001·Alimentary Pharmacology & Therapeutics·S J EdwardsL Lundell
Jan 12, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·M DojoM Kuriyama

❮ Previous
Next ❯

Citations

Aug 17, 2004·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·H Koop
Feb 9, 2005·Der Internist·I SchiefkeK Caca
Oct 18, 2008·European Journal of Clinical Pharmacology·Julia KirchheinerJürgen Brockmöller
Mar 12, 2004·Journal of Gastroenterology and Hepatology·Kwong Ming FockJose Sollano
Jan 18, 2006·Annual Review of Medicine·Michel EichelbaumWilliam E Evans
Dec 27, 2007·PloS One·Beverley J SheaJeremy M Grimshaw
May 6, 2005·Clinical Pharmacokinetics·Catherine LitalienChristophe Faure
May 7, 2008·Drugs·Vandana BoparaiGeorge Triadafilopoulos
Apr 1, 2011·Clinical Journal of Gastroenterology·T P Rakesh
Oct 25, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Abhishek DeshpandeAdrian V Hernandez
Dec 17, 2015·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Lara Aguilera-CastroAgustín Albillos-Martínez
Aug 11, 2005·Alimentary Pharmacology & Therapeutics·G Manes
Aug 17, 2005·European Journal of Clinical Investigation·J Mössner, K Caca
Jul 13, 2004·Basic & Clinical Pharmacology & Toxicology·Ulrich KlotzGerhard Treiber
Nov 30, 2012·Journal of Gastroenterology and Hepatology·Abhishek DeshpandeAdrian V Hernandez
Mar 13, 2010·Alimentary Pharmacology & Therapeutics·J JohnstoneM Loeb
Dec 14, 2004·Best Practice & Research. Clinical Gastroenterology·Ray J Playford
Nov 18, 2015·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Waheed AsgharFakhreddin Jamali
May 8, 2007·Primary Care·Riza Tady Conroy, Bushra Siddiqi
Dec 14, 2006·Expert Opinion on Pharmacotherapy·Dawn D Ferguson, Kenneth R DeVault
Jun 22, 2016·Journal of Gastroenterology·Katsuhiko IwakiriTooru Shimosegawa
Nov 8, 2017·Digestive Diseases and Sciences·Yu-Min KungYao-Kuang Wang
Nov 12, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Erwin Biecker
Jun 14, 2013·The Cochrane Database of Systematic Reviews·Ignacio NeumannGrigorios I Leontiadis
Jun 15, 2006·The American Journal of Gastroenterology·Gianpiero ManesGabriele B Porro
Feb 25, 2014·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Yeoun Su JungChang Heon Yang
Jun 9, 2005·Pharmazie in unserer Zeit·Ulrich Klotz
Jun 9, 2005·Pharmazie in unserer Zeit·Karl-Hans Holtermüller
Jul 18, 2020·Alimentary Pharmacology & Therapeutics·Emilio J Laserna-MendietaUNKNOWN EUREOS EoE CONNECT Research group
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Pierre Lao-SirieixRebecca C Fitzgerald
Aug 2, 2016·Deutsches Ärzteblatt International·Joachim Mössner
Jun 15, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Pilar NavarroUNKNOWN EUREOS EoE CONNECT research group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.